Despite setbacks and funding cuts — and a quieting of the hype blaring its arrival — multiple CRISPR-based trials are ...

A team at Massachusetts General Hospital uncovered that an immune defense protein, Resistin-like molecule gamma, attacks ...

RELMy from immune cells disrupts heart rhythm after heart attacks. Blocking it may improve survival. In a new study published in Science, researchers at Massachusett Hospital (MGH) uncover a ...

Anomalous aortic origin of the coronary arteries (AAOCA) is a rare but important cause of sudden cardiac death, particularly in young athletes. Risk assessment of AAOCA includes anatomical and ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Guideline-directed ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. We conducted a systematic ...

Coronary artery disease (CAD) is a big deal, affecting millions worldwide. For a long time, figuring out who has it and how serious it is could be tricky. But now, there’s a new way to look at things.

Patients benefit from antiplatelet therapy after coronary-artery bypass grafting (CABG) for an acute coronary syndrome. Whether the addition of ticagrelor to aspirin, as compared with aspirin alone, ...

A commonly prescribed drug could be more effective than aspirin for long-term heart disease prevention. Analysis of nearly 29,000 patients with coronary artery disease (CAD) suggests the blood thinner ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Atherosclerosis is characterized by the ...